Intellectual Property India Publishes Patent Application for 'Method And Kit For Predicting Efficacy Of Treatment With Immunotherapeutic Agent On Patient With Mucosal Lesion' Filed by Nihon University; and Glovacc Co. Ltd.

MUMBAI, India, Aug. 1 -- Intellectual Property India has published a patent application (202517066880 A) filed by Nihon University; and Glovacc Co. Ltd., Tokyo, on July 14, for 'method and kit for predicting efficacy of treatment with immunotherapeutic agent on patient with mucosal lesion.'

Inventor(s) include Kawana Kei; Katoh Yuki; and Sewaki Tomomitsu.

The application for the patent was published on Aug. 1, under issue no. 31/2025.

According to the abstract released by the Intellectual Property India: "The present invention provides a novel method and kit for predicting the efficacy of treatment with an immunotherapeutic agent on a patient with a mucosal lesion. The present invention is a method for predicting the efficacy of treatment with an immunotherapeutic agent on a patient with a mucosal lesion, the method comprising a step for measuring the expression level of CD86 in a biological sample derived from a patient with a mucosal lesion. The present invention is a kit for use in the above method, the kit comprising a substance that binds specifically to CD86, or forward and reverse primers for amplifying nucleic acids encoding CD86."

The patent application was internationally filed on Jan. 18, 2024, under International application No.PCT/JP2024/001302.

Disclaimer: Curated by HT Syndication.